It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JAZZ’s FA Score shows that 0 FA rating(s) are green whilePLAY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JAZZ’s TA Score shows that 6 TA indicator(s) are bullish while PLAY’s TA Score has 3 bullish TA indicator(s).
JAZZ (@Biotechnology) experienced а +2.36% price change this week, while PLAY (@Movies/Entertainment) price change was -7.22% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.
The average weekly price growth across all stocks in the @Movies/Entertainment industry was +0.72%. For the same industry, the average monthly price growth was +7.22%, and the average quarterly price growth was +14.22%.
JAZZ is expected to report earnings on Nov 05, 2025.
PLAY is expected to report earnings on Sep 03, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Movies/Entertainment (+0.72% weekly)Movies/entertainment industry include companies that produce and distribute motion pictures, and companies that operate general entertainment facilities like amusement parks and bowling centers. Some companies in this industry also have professional sports franchises. Live Nation Entertainment, Inc., Liberty Media Corp. and Viacom Inc. are some of the biggest companies in this space.
JAZZ | PLAY | JAZZ / PLAY | |
Capitalization | 6.83B | 2.52B | 271% |
EBITDA | 1.25B | 482M | 259% |
Gain YTD | -8.348 | 2.604 | -321% |
P/E Ratio | 15.34 | 22.92 | 67% |
Revenue | 4.07B | 2.18B | 186% |
Total Cash | 2.57B | 82.6M | 3,114% |
Total Debt | 5.42B | 2.94B | 184% |
JAZZ | PLAY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 99 | 75 | |
SMR RATING 1..100 | 61 | 50 | |
PRICE GROWTH RATING 1..100 | 54 | 47 | |
P/E GROWTH RATING 1..100 | 86 | 12 | |
SEASONALITY SCORE 1..100 | 9 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JAZZ's Valuation (69) in the Pharmaceuticals Other industry is in the same range as PLAY (93) in the Restaurants industry. This means that JAZZ’s stock grew similarly to PLAY’s over the last 12 months.
PLAY's Profit vs Risk Rating (75) in the Restaurants industry is in the same range as JAZZ (99) in the Pharmaceuticals Other industry. This means that PLAY’s stock grew similarly to JAZZ’s over the last 12 months.
PLAY's SMR Rating (50) in the Restaurants industry is in the same range as JAZZ (61) in the Pharmaceuticals Other industry. This means that PLAY’s stock grew similarly to JAZZ’s over the last 12 months.
PLAY's Price Growth Rating (47) in the Restaurants industry is in the same range as JAZZ (54) in the Pharmaceuticals Other industry. This means that PLAY’s stock grew similarly to JAZZ’s over the last 12 months.
PLAY's P/E Growth Rating (12) in the Restaurants industry is significantly better than the same rating for JAZZ (86) in the Pharmaceuticals Other industry. This means that PLAY’s stock grew significantly faster than JAZZ’s over the last 12 months.
JAZZ | PLAY | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago74% |
Stochastic ODDS (%) | 3 days ago60% | 3 days ago81% |
Momentum ODDS (%) | 3 days ago65% | 3 days ago79% |
MACD ODDS (%) | 3 days ago71% | 3 days ago88% |
TrendWeek ODDS (%) | 3 days ago62% | 3 days ago80% |
TrendMonth ODDS (%) | 3 days ago66% | 3 days ago83% |
Advances ODDS (%) | 5 days ago61% | 18 days ago76% |
Declines ODDS (%) | 3 days ago56% | 5 days ago82% |
BollingerBands ODDS (%) | 3 days ago79% | 3 days ago77% |
Aroon ODDS (%) | 3 days ago56% | 3 days ago82% |